SCHEMBL25944753

SCHEMBL25944753

CC(C)Cc1cccc2cc(Cn3cccc(NC(=O)CCC/C=C/C(=O)N(C)C)c3=O)[nH]c12

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25945536 0.92 MAP4K1 (0.62) MAP4K1
SCHEMBL25944728 0.91 MAP4K1 (0.59) MAP4K1
SCHEMBL25944793 0.90 MAP4K1 (0.60) MAP4K1
SCHEMBL25944756 0.89 MAP4K1 (0.57) MAP4K1
SCHEMBL21703314 0.88 MAP4K1 (0.58) MAP4K1
SCHEMBL25944945 0.88 MAP4K1 (0.57) MAP4K1
SCHEMBL25950631 0.88 MAP4K1 (0.57) MAP4K1
SCHEMBL25939274 0.86 MAP4K1 (0.60) MAP4K1
SCHEMBL21683596 0.85 MAP4K1 (0.77) MAP4K1
SCHEMBL21683757 0.85 MAP4K1 (0.77) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 EP disclosed